Can antihypertensive drugs cause cancer? Can antihypertensive drugs cause cancer? In fact, people often ask doctors whether antihypertensive drugs...
Drugs
FDA approved the first anti-VEGFR/EGFR-TKI combination program for first-line NSCLC FDA approved the first anti-VEGFR/EGFR-TKI combination program for first-line NSCLC. ...
Alzheimer's disease: another new drug failed Alzheimer's disease: another new drug failed. Where is the treatment for Alzheimer's disease?...
Statins: 5 suggestions to keep your blood fat and blood sugar low! Statins: 5 suggestions to keep your blood...
Hexon protein: The best choice for adenovirus reagent development! Hexon protein: The best choice for adenovirus reagent development! VirionSerion's adenovirus...
New therapies and new drugs for lung cancer New therapies and new drugs for lung cancer. Lung cancer is a...
Daratumumab approved to treat AL amyloidosis Daratumumab approved to treat AL amyloidosis. Amyloidosis is a rare and potentially fatal...
Nutrient-rich production medium of CHO cell line development platform-based Nutrient-rich production medium of CHO cell line development platform-based. Abstract: With...
HBx protein: Essential for replication after HBV infection HBx protein: Essential for replication after HBV infection. HBx protein is...
Challenges and prospects of mRNA therapy Challenges and prospects of mRNA therapy. In the pharmaceutical industry, mRNA-based treatment methods...
Do I have to take lipid-lowering drugs for high blood lipids? Do I have to take lipid-lowering drugs for high...
Chemotherapy Targeting Immunity: Greater Side Effects is good? Chemotherapy, targeting, immunity, the greater the adverse reaction, the better...
Enhertu treats advanced gastric cancer with 41% less on mortality rate Enhertu treats advanced gastric cancer with 41% less...
FDA approves the first light chain amyloidosis drug FDA approves the first light chain amyloidosis drug. FDA approval is based...
Crizotinib was approved to treat anaplastic large cell lymphoma Crizotinib was approved to treat anaplastic large cell lymphoma. The...
“Longevity medicine” NMN banned in China "Longevity medicine" NMN banned in China. Previously, NMNhas become the focus of the...
Drugs of allosteric modulators derived from natural products Drugs of allosteric modulators derived from natural products. Drugs that are...
CRISPR: Three new developments in the field of gene editing CRISPR: Three new developments in the field of gene...
History of IgG glycosylation and where we are now History of IgG glycosylation and where we are now. IgG glycosylation...
Helicobacter pylori: 2 drugs with good effects and few side effects Helicobacter pylori: 2 drugs withgood effects and few...
Important clinical trials in the first half of 2021 Important clinical trials in the first half of 2021. Clinical...
Capillary electrophoresis: Application in protein drug analysis Capillary electrophoresis: Application in protein drug analysis. Capillary electrophoresis (CE) has...
Hepatitis B: New drug GLP-26 under development Hepatitis B: New drug GLP-26 under development. Preclinical, potential cardiotoxic cynomolgus PK study....
Lung squamous carcinoma: First Chinese PD-1 Antibody Approved Lung squamous carcinoma: First Chinese PD-1 Antibody Approved. Some people say...
SinoMab: Third-generation reversible covalent BTK inhibitor. SinoMab anounced Phase I clinical trial of the third-generation reversible covalent BTK...
HER2-positive gastric cancer's first ADC drug! HER2-positive gastric cancer's first ADC drug! AstraZeneca/Daiichi Sankyo Enhertu is approved by...
Muscle damage: Side effects caused by statin Muscle damage: Side effects caused by statin. A patient said that he...
Statins and Aspirin: Basic drugs for cardiovascular and cerebrovascular diseases Statins and Aspirin: Basic drugs for cardiovascular and cerebrovascular...
Tilelizumab chemotherapy: Esophageal squamous cell carcinoma Tilelizumab chemotherapy: Esophageal squamous cell carcinoma. Tilelizumab combined with chemotherapy: patients with stage...
FDA: Novartis' new-generation IgE antibody qualified as a breakthrough drug FDA: Novartis' new-generation IgE antibody qualified as a breakthrough...